SCHEMBL7700304

SCHEMBL7700304

CCCc1cc(CCC)cc(CCC)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
PTGS2 P35354 3/20 0.42
CYP3A4 P08684 2/20 0.42
LPL P06858 1/20 0.42
LIPG Q9Y5X9 1/20 0.42
GPR84 Q9NQS5 2/20 0.41
HTT P42858 2/20 0.40
NPC1 O15118 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CA2 P00918 1/20 0.39
ALDH1A1 P00352 2/20 0.38
FFAR4 Q5NUL3 1/20 0.36
MGLL Q99685 1/20 0.36
PLK1 P53350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2769207 0.90 CNR1 (0.41) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL3697947 0.90 CNR1 (0.41) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL6534660 0.87 HPGD (0.56) PTGS2CYP3A4GPR84HTTNPC1
SCHEMBL16962402 0.87 FFAR4 (0.44) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL16962400 0.85 CNR1 (0.38) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL4575378 0.85 CNR1 (0.38) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL18854254 0.85 POLB (0.38) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL3362484 0.85 PTGS2 (0.62) CNR1CNR2PTGS2CYP3A4GPR84
SCHEMBL9220960 0.85 ACHE (0.43) CNR1CNR2PTGS2CYP3A4LPL
SCHEMBL14473767 0.85 CNR1 (0.38) CNR1CNR2PTGS2CYP3A4LPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070796-A1 METHOD OF MANUFACTURING INORGANIC OXIDE NANOFIBER, AND NANOSTRUCTURE SONY GROUP CORP (JP) 2026-03-12 US claimed
WO-2024085009-A1 METHOD FOR PRODUCING INORGANIC OXIDE NANOFIBER, AND NANOSTRUCTURE ソニーグループ株式会社 2024-04-25 WO claimed
US-6355826-B1 HALOMETHYLATION AN AROMATIC ALDEHYDE COMPOUND AND SALT FORMATION THE GOODYEAR TIRE & RUBBER COMPANY 2002-03-12 US claimed
EP-0903338-A2 Synthesis of stable nitrile oxide compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1999-03-24 EP claimed
US-20260070796-A1 METHOD OF MANUFACTURING INORGANIC OXIDE NANOFIBER, AND NANOSTRUCTURE SONY GROUP CORP (JP) 2026-03-12 US disclosed
WO-2024085009-A1 METHOD FOR PRODUCING INORGANIC OXIDE NANOFIBER, AND NANOSTRUCTURE ソニーグループ株式会社 2024-04-25 WO disclosed
EP-3263605-B1 METHOD FOR PREPARING MODIFIED CONJUGATED DIENE RUBBER ZEON CORP (JP) 2019-11-13 EP disclosed
US-10414835-B2 Method of production of modified conjugated diene rubber ZEON CORPORATION (JP) 2019-09-17 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
EP-2930179-B1 RUTHENIUM COMPLEX AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM TOSOH CORP (JP) 2018-09-05 EP disclosed
CN-105073808-B The manufacturing method of radial conjugated diene rubber 日本瑞翁株式会社 2018-06-29 CN disclosed
EP-2980111-B1 METHOD FOR PRODUCING RADIAL CONJUGATED DIENE RUBBER ZEON CORP (JP) 2018-01-31 EP disclosed
US-5334370-A X-ray contrast mixtures for diagnostic radiology consisting of iodo alkylbenzene, a polysaccharide salt or a anionic polymers STERLING WINTHROP INC. (US) 1994-08-02 US disclosed
US-5308607-A FOR USE IN DIAGNOSTIC RADIOLOGY STERLING WINTHROP INC. (US) 1994-05-03 US disclosed
EP-0233450-B1 LINEAR SALICYLIC ACID COPOLYMERS AND THEIR METAL SALTS, PRODUCTION PROCESS THEREOF, COLOR-DEVELOPING AGENTS COMPRISING METAL-RESINS OF THE COPOLYMERS, AND COLOR-DEVELOPING SHEETS EMPLOYING THE AGENTS MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-03-11 EP disclosed
US-4783521-A Linear salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal-resins of the copolymers MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1988-11-08 US disclosed
EP-0233450-A2 Linear salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal-resins of the copolymers, and color-developing sheets employing the agents MITSUI TOATSU CHEMICALS, Inc. (JP) 1987-08-26 EP disclosed
US-4110270-A ALKALI METAL SALT OF TOLUENE- OR BENZENE-SULFINIC ACID AS CATALYST BASF WYANDOTTE CORPORATION (US) 1978-08-29 US disclosed
US-4092276-A ALKALI METAL SALT OF AN ORGANIC PHOSPHINIC ACID AS CATALYST BASF WYANDOTTE CORPORATION (US) 1978-05-30 US disclosed
US-4005156-A Novel flame retardant compositions of matter UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070796-A1 METHOD OF MANUFACTURING INORGANIC OXIDE NANOFIBER, AND NANOSTRUCTURE MAPT, APP, NOS3 CNR1 4547/4885CNR2 3725/4885PTGS2 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.